<p>Edgestream Partners L.P. 在第二季度購買了 Pediatrix Medical Group, Inc. (NYSE:MD - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 表格。該公司購買了 53,175 股該公司的股票，價值約為 763,000 美元。截至其最近向證券交易委員會提交的文件，Edgestream Partners L.P. 擁有 Pediatrix Medical Group 0.06% 的股份。</p>
<ul>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
</ul>
<p>其他機構投資者和對沖基金最近也對該公司的持倉進行了調整。波士頓合夥公司在第一季度將其在 Pediatrix Medical Group 的持股增加了 1.3%。波士頓合夥公司現在擁有 1,981,889 股該公司的股票，價值 27,990,000 美元，在上個季度又收購了 25,536 股。美國世紀公司在第二季度將其在 Pediatrix Medical Group 的持倉提高了 28.6%。美國世紀公司現在擁有 1,931,867 股該公司的股票，價值 27,722,000 美元，在此期間又購買了 430,029 股。英維斯科有限公司在第一季度將其在 Pediatrix Medical Group 的股份增加了 9.3%。英維斯科有限公司現在擁有 863,269 股該公司的股票，價值 12,509,000 美元，在上個季度又購買了 73,157 股。Bridgeway Capital Management LLC 在第一季度將其在 Pediatrix Medical Group 的股份增加了 1.7%。Bridgeway Capital Management LLC 現在擁有 554,452 股該公司的股票，價值 8,034,000 美元，在此期間又購買了 9,007 股。最後，Nuveen LLC 在第一季度購買了 Pediatrix Medical Group 的新股份，價值約為 8,024,000 美元。機構投資者擁有該公司 97.71% 的股票。</p>
<h2>Pediatrix Medical Group 股票下跌 0.7%</h2>
<p>MD 股票在週五開盤價為 22.14 美元。該公司的債務與股本比率為 0.65，流動比率為 1.83，速動比率為 1.83。該股票的市值為 19 億美元，市盈率為 11.65，貝塔值為 0.77。Pediatrix Medical Group, Inc. 的 52 周低點為 11.84 美元，52 周高點為 24.99 美元。該公司的 50 日移動平均線為 19.94 美元，200 日移動平均線為 16.47 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p>Pediatrix Medical Group (NYSE:MD - 獲取免費報告) 最近在 11 月 3 日星期一公佈了其財報。該公司報告每股收益 (EPS) 為 0.67 美元，超出分析師共識預期的 0.46 美元，超出幅度為 0.21 美元。Pediatrix Medical Group 的股本回報率為 20.45%，淨利潤率為 8.44%。該公司在本季度的收入為 4.9288 億美元，而分析師預期為 4.7645 億美元。去年同期，該公司每股收益為 0.44 美元。Pediatrix Medical Group 本季度的收入較去年同期下降了 3.6%。平均而言，賣方分析師預計 Pediatrix Medical Group, Inc. 在當前財年將發佈每股收益 1.38 美元。</p>
<h2>內部活動</h2>
<p>在其他 Pediatrix Medical Group 的新聞中，董事 Michael A. Rucker 於 11 月 17 日星期一出售了 10,478 股該公司的股票。該股票以平均價格 23.00 美元出售，總交易額為 240,994.00 美元。交易後，該董事持有 59,101 股該公司的股票，價值 1,359,323 美元。此次交易使其持股減少了 15.06%。該交易已在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接獲取。此外，董事 Laura A. Linynsky 於 11 月 6 日星期四出售了 10,000 股該公司的股票。該股票以平均價格 21.65 美元出售，總價值為 216,500.00 美元。交易後，該董事直接持有 32,232 股該公司的股票，價值 697,822.80 美元。此次交易使其持股減少了 23.68%。有關此次出售的更多細節可在官方 SEC 披露中找到。公司內部人士擁有該公司 0.90% 的股票。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
<p>一些股票分析師對該股票發佈了報告。Wall Street Zen 在 10 月 4 日星期六的研究報告中將 Pediatrix Medical Group 的股票評級從 “買入” 上調至 “強力買入”。Leerink Partners 在 9 月 5 日星期五的研究報告中將 Pediatrix Medical Group 的目標價從 14.50 美元上調至 17.00 美元，並給予該股票 “市場表現” 評級。Weiss Ratings 在 12 月 1 日星期一的報告中重申了對 Pediatrix Medical Group 股票的 “持有 (c+)” 評級。Zacks Research 在 11 月 21 日星期五的報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。最後，瑞銀集團在 11 月 5 日星期三的研究報告中將 Pediatrix Medical Group 的目標價從 16.50 美元上調至 23.00 美元，並給予該公司 “中性” 評級。一位股票研究分析師對該股票給予了強力買入評級，一位給予了買入評級，四位給予了持有評級。根據 MarketBeat 的數據，Pediatrix Medical Group 目前的平均評級為 “適度買入”，平均目標價為 21.00 美元。</p>
<p><strong>獲取我們關於 MD 的最新報告</strong></p>
<h2>Pediatrix Medical Group 公司簡介</h2>
<p>(免費報告)</p>
<p>Pediatrix Medical Group, Inc. 及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，例如通過新生兒醫學專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內為早產或有併發症的嬰兒提供臨牀護理。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而非 Pediatrix Medical Group</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Ulta 的股票可能會迎來上漲——未來有 20% 的上漲空間？</li>
<li>消費品股票解析</li>
<li>比爾·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>如何知道該購買哪種加密貨幣：投資者指南</li>
<li>MarketBeat 周度回顧 – 12/1 - 12/5</li>
</ul>
<p><strong>想看看其他對 MD 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Pediatrix Medical Group, Inc. (NYSE:MD - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
<p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 Pediatrix Medical Group 並不在名單上。</p>
<p>雖然 Pediatrix Medical Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Edgestream Partners L.P. 投資了 Pediatrix Medical Group，購買了 53,175 股，價值 763,000 美元。其他投資者調整了他們的持股，波士頓合夥人、美國世紀公司等增加了他們的股份。Pediatrix 報告了強勁的收益，超出了分析師的預期，並獲得了華爾街分析師的積極評級。公司內部人士出售了股份，減少了他們的持倉。該股票的市值為 19 億美元，市盈率為 11.65。分析師預測增長，華爾街 Zen 給出了強買評級</p>

<p>Edgestream Partners L.P. bought a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 53,175 shares of the company's stock, valued at approximately $763,000. Edgestream Partners L.P. owned 0.06% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>Edgestream Partners L.P. 在第二季度購買了 Pediatrix Medical Group, Inc. (NYSE:MD - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 表格。該公司購買了 53,175 股該公司的股票，價值約為 763,000 美元。截至其最近向證券交易委員會提交的文件，Edgestream Partners L.P. 擁有 Pediatrix Medical Group 0.06% 的股份。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently made changes to their positions in the company. Boston Partners boosted its holdings in Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company's stock valued at $27,990,000 after acquiring an additional 25,536 shares during the last quarter. American Century Companies Inc. lifted its position in Pediatrix Medical Group by 28.6% during the 2nd quarter. American Century Companies Inc. now owns 1,931,867 shares of the company's stock valued at $27,722,000 after purchasing an additional 430,029 shares during the period. Invesco Ltd. boosted its stake in shares of Pediatrix Medical Group by 9.3% in the 1st quarter. Invesco Ltd. now owns 863,269 shares of the company's stock valued at $12,509,000 after purchasing an additional 73,157 shares during the last quarter. Bridgeway Capital Management LLC grew its position in shares of Pediatrix Medical Group by 1.7% during the 1st quarter. Bridgeway Capital Management LLC now owns 554,452 shares of the company's stock worth $8,034,000 after buying an additional 9,007 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Pediatrix Medical Group during the first quarter worth approximately $8,024,000. Institutional investors own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金最近也對該公司的持倉進行了調整。波士頓合夥公司在第一季度將其在 Pediatrix Medical Group 的持股增加了 1.3%。波士頓合夥公司現在擁有 1,981,889 股該公司的股票，價值 27,990,000 美元，在上個季度又收購了 25,536 股。美國世紀公司在第二季度將其在 Pediatrix Medical Group 的持倉提高了 28.6%。美國世紀公司現在擁有 1,931,867 股該公司的股票，價值 27,722,000 美元，在此期間又購買了 430,029 股。英維斯科有限公司在第一季度將其在 Pediatrix Medical Group 的股份增加了 9.3%。英維斯科有限公司現在擁有 863,269 股該公司的股票，價值 12,509,000 美元，在上個季度又購買了 73,157 股。Bridgeway Capital Management LLC 在第一季度將其在 Pediatrix Medical Group 的股份增加了 1.7%。Bridgeway Capital Management LLC 現在擁有 554,452 股該公司的股票，價值 8,034,000 美元，在此期間又購買了 9,007 股。最後，Nuveen LLC 在第一季度購買了 Pediatrix Medical Group 的新股份，價值約為 8,024,000 美元。機構投資者擁有該公司 97.71% 的股票。</p>
</div><h2>Pediatrix Medical Group Stock Down 0.7%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 0.7%</h2>
</div><p>MD stock opened at $22.14 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.83 and a quick ratio of 1.83. The stock has a market capitalization of $1.90 billion, a P/E ratio of 11.65 and a beta of 0.77. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $24.99. The business has a 50-day moving average of $19.94 and a 200-day moving average of $16.47.</p>
<div class="lb-trans"><p>MD 股票在週五開盤價為 22.14 美元。該公司的債務與股本比率為 0.65，流動比率為 1.83，速動比率為 1.83。該股票的市值為 19 億美元，市盈率為 11.65，貝塔值為 0.77。Pediatrix Medical Group, Inc. 的 52 周低點為 11.84 美元，52 周高點為 24.99 美元。該公司的 50 日移動平均線為 19.94 美元，200 日移動平均線為 16.47 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.21. Pediatrix Medical Group had a return on equity of 20.45% and a net margin of 8.44%.The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. During the same quarter last year, the firm earned $0.44 EPS. Pediatrix Medical Group's revenue for the quarter was down 3.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group (NYSE:MD - 獲取免費報告) 最近在 11 月 3 日星期一公佈了其財報。該公司報告每股收益 (EPS) 為 0.67 美元，超出分析師共識預期的 0.46 美元，超出幅度為 0.21 美元。Pediatrix Medical Group 的股本回報率為 20.45%，淨利潤率為 8.44%。該公司在本季度的收入為 4.9288 億美元，而分析師預期為 4.7645 億美元。去年同期，該公司每股收益為 0.44 美元。Pediatrix Medical Group 本季度的收入較去年同期下降了 3.6%。平均而言，賣方分析師預計 Pediatrix Medical Group, Inc. 在當前財年將發佈每股收益 1.38 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of the business's stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $23.00, for a total transaction of $240,994.00. Following the transaction, the director owned 59,101 shares of the company's stock, valued at $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, Director Laura A. Linynsky sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $21.65, for a total value of $216,500.00. Following the transaction, the director directly owned 32,232 shares in the company, valued at $697,822.80. The trade was a 23.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Pediatrix Medical Group 的新聞中，董事 Michael A. Rucker 於 11 月 17 日星期一出售了 10,478 股該公司的股票。該股票以平均價格 23.00 美元出售，總交易額為 240,994.00 美元。交易後，該董事持有 59,101 股該公司的股票，價值 1,359,323 美元。此次交易使其持股減少了 15.06%。該交易已在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接獲取。此外，董事 Laura A. Linynsky 於 11 月 6 日星期四出售了 10,000 股該公司的股票。該股票以平均價格 21.65 美元出售，總價值為 216,500.00 美元。交易後，該董事直接持有 32,232 股該公司的股票，價值 697,822.80 美元。此次交易使其持股減少了 23.68%。有關此次出售的更多細節可在官方 SEC 披露中找到。公司內部人士擁有該公司 0.90% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
</div><p>A number of equities analysts have issued reports on the stock. Wall Street Zen raised shares of Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, October 4th. Leerink Partners raised their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a &#34;market perform&#34; rating in a research report on Friday, September 5th. Weiss Ratings reiterated a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a report on Monday, December 1st. Zacks Research upgraded Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 21st. Finally, UBS Group upped their price target on Pediatrix Medical Group from $16.50 to $23.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $21.00.</p>
<div class="lb-trans"><p>一些股票分析師對該股票發佈了報告。Wall Street Zen 在 10 月 4 日星期六的研究報告中將 Pediatrix Medical Group 的股票評級從 “買入” 上調至 “強力買入”。Leerink Partners 在 9 月 5 日星期五的研究報告中將 Pediatrix Medical Group 的目標價從 14.50 美元上調至 17.00 美元，並給予該股票 “市場表現” 評級。Weiss Ratings 在 12 月 1 日星期一的報告中重申了對 Pediatrix Medical Group 股票的 “持有 (c+)” 評級。Zacks Research 在 11 月 21 日星期五的報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。最後，瑞銀集團在 11 月 5 日星期三的研究報告中將 Pediatrix Medical Group 的目標價從 16.50 美元上調至 23.00 美元，並給予該公司 “中性” 評級。一位股票研究分析師對該股票給予了強力買入評級，一位給予了買入評級，四位給予了持有評級。根據 MarketBeat 的數據，Pediatrix Medical Group 目前的平均評級為 “適度買入”，平均目標價為 21.00 美元。</p>
</div><p><strong>Get Our Latest Report on MD</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 MD 的最新報告</strong></p>
</div><h2>Pediatrix Medical Group Company Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. 及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，例如通過新生兒醫學專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內為早產或有併發症的嬰兒提供臨牀護理。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li>
<li>Consumer Staples Stocks, Explained</li>
<li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li>
<li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li>
<li>MarketBeat Week in Review – 12/1 - 12/5</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非 Pediatrix Medical Group</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Ulta 的股票可能會迎來上漲——未來有 20% 的上漲空間？</li>
<li>消費品股票解析</li>
<li>比爾·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>如何知道該購買哪種加密貨幣：投資者指南</li>
<li>MarketBeat 周度回顧 – 12/1 - 12/5</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MD?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 MD 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Pediatrix Medical Group, Inc. (NYSE:MD - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 Pediatrix Medical Group 並不在名單上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Pediatrix Medical Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Edgestream Partners L.P. 對 Pediatrix Medical Group, Inc. $MD 進行了新的投資